Lenvatinib is a tyrosine kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). It is an anti-tumour medicine, and it is used in treating patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy, and patients with unresectable hepatocellular carcinoma. The medicine is supplied in 10 mg and 4 mg capsules for oral administration. Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumour growth, and cancer progression. Lenvatinib price is affordable in India, and this medicine is readily available with multiple generic medicine suppliers. The Indian Pharma is one of the licensed suppliers, supplying drugs globally for more than 7 years.
Bet88 Photo
Win606
Hear Again
Property Management Dubai
The Rush Funplex
188v Spot
Marcella & Co Aesthetics
Hbbet
Go 88 Audio
Go88